Experimental validation of mhc class i and ii peptide-based potential vaccine candidates for human papilloma virus using sprague-dawly models

HIGHLIGHTS

• who: Mehreen Ismail et al. from the Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan School of Information and Technology, Wenzhou Business College, Wenzhou, China have published the research: Experimental Validation of MHC Class I and II Peptide-Based Potential Vaccine Candidates for Human Papilloma Virus Using Sprague-Dawly Models, in the Journal: Molecules 2023, 1687 of 10/02/2023
• what: HPV peptides are potential vaccine candidates to bind MHC class I and II molecules.
• how: The authors used an immunoinformatics approach to identify potential T-cell epitopes of HPV . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.